In 2022, Qi et al. uncovered the involvement of circ_RPPH1 and Rho GTPase activator protein 1 (ARHGAP1), coupled with the decreased expression of miR-542-3p, in breast cancer (BC) tissues of cancer patients. Here, ARHGAP1 is linked to breast carcinoma.